FT News Briefing cover image

Credit Suisse bondholders sue

FT News Briefing

00:00

Legal Challenges to Mifepristone and Its Impact on Pharma Innovation

This chapter explores the recent court ruling that overturned the FDA approval of the abortion pill Mifepristone, raising concerns about the future of pharmaceutical innovation in the U.S. Experts discuss the broader implications of eroding the FDA's authority and the potential deterrent effects on drug investment and research and development.

Play episode from 05:50
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app